Back to JONES FINANCIAL COMPANIES LLLP JONES FINANCIAL COMPANIES LLLP

GANXGANX
Showing 8 of 9 quarters

Position history for JONES FINANCIAL COMPANIES LLLPJONES FINANCIAL COMPANIES LLLP's holdings in GAIN THERAPEUTICS INC

JONES FINANCIAL COMPANIES LLLP holds 608,592 shares of GANX (GAIN THERAPEUTICS INC), worth $1.1M as of 2026-Q2. The position was decreased (-3.6% shares). GANX represents 0.0% of JONES FINANCIAL COMPANIES LLLP's portfolio.

Current Value

$1.1M

Current Shares

608,592

Total Value Change

+$958,571

Total Shares Change

+555,092

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
608,592
-3.6%
$1.1M0.0%$2.03
0
2026-Q1
Decreased
631,615
-10.1%
$1.2M0.0%$2.63
0
2025-Q4
Increased
702,213
+3.8%
$2.3M0.0%$3.05
27
2025-Q3
Decreased
676,822
-0.0%
$1.2M0.0%$1.81
0
2025-Q2
Increased
676,888
+58.3%
$1.3M0.0%$1.97
36
2025-Q1
Increased
427,700
+335.3%
$808,3530.0%$1.89
40
2024-Q4
Increased
98,250
+83.6%
$212,2200.0%$2.18
35
2024-Q3
Increased
53,500
+664.3%
$106,4650.0%$1.99
35

Other major holders of GANX: GREENLIGHT CAPITAL INC, Gotham Asset Management, LLC, MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used